Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Pharmacogenetics|April 26, 2000
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitorsS Ekins, G Bravi, S Binkley, et al.Cureus|March 23, 2016
Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative RadiotherapyAadel A Chaudhuri, Michael S Binkley, Sonya Aggarwal, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitorsS Ekins, G Bravi, S Binkley, et al.The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitorsS Ekins, G Bravi, S Binkley, et al.Ejhaem|February 26, 2024
Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patientDasom Lee, Anmol Goyal, William L Wang, et al.Journal of Clinical Psychology|December 19, 2006
Submissive voices dominate in depression: assimilation analysis of a helpful sessionKaterine Osatuke, James K Mosher, Jacob Z Goldsmith, et al.International Journal of Radiation Oncology, Biology, Physics|February 3, 2016
Dosimetric Factors and Toxicity in Highly Conformal Thoracic ReirradiationMichael S Binkley, Susan M Hiniker, Aadel Chaudhuri, et al.Leukemia & Lymphoma|July 11, 2015
A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapyMichael S Binkley, Susan M Hiniker, Sharon Wu, et al.Radiation Oncology (London, England)|March 16, 2016
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumorsMichael S Binkley, Joseph B Shrager, Aadel Chaudhuri, et al.Cureus|May 27, 2016
Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent BevacizumabAadel A Chaudhuri, Jie Jane Chen, Justin N Carter, et al.Pageof 11